Trials (Dec 2020)

Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

  • Timothy Devos,
  • Tatjana Geukens,
  • Alexander Schauwvlieghe,
  • Kevin K. Ariën,
  • Cyril Barbezange,
  • Myriam Cleeren,
  • Veerle Compernolle,
  • Nicolas Dauby,
  • Daniël Desmecht,
  • David Grimaldi,
  • Bart N. Lambrecht,
  • Anne Luyten,
  • Piet Maes,
  • Michel Moutschen,
  • Marta Romano,
  • Lucie Seyler,
  • Michel Toungouz Nevessignsky,
  • Katleen Vandenberghe,
  • Johan van Griensven,
  • Geert Verbeke,
  • Erika Vlieghe,
  • Jean Cyr Yombi,
  • Laurens Liesenborghs,
  • Peter Verhamme,
  • Geert Meyfroidt

DOI
https://doi.org/10.1186/s13063-020-04947-2
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 1

Abstract

Read online

An amendment to this paper has been published and can be accessed via the original article.